Concepedia

Sarah Hamidi

SH

Statistics

Publications

5

Citations

141

H-Index

5

Active since

2020

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Sarah Hamidi is an author at The University of Texas MD Anderson Cancer Center.

Publications per year

2020–2024

5

Publications

5

Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF <sup>V600E</sup> -Mutated Anaplastic Thyroid Carcinoma

Sarah Hamidi, Priyanka Iyer, Ramona Dadu et al. · Thyroid · 2024 · 61 citations

Initial Management of <i>BRAF </i>V600E-Variant Anaplastic Thyroid Cancer

Sarah Hamidi, Ramona Dadu, Mark Zafereo et al. · JAMA Oncology · 2024 · 28 citations

Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side Effects

Sarah Hamidi, Andrée Boucher, Bernard Lemieux et al. · Journal of the Endocrine Society · 2022 · 21 citations · Full text

Brown tumor of the iliac crest initially misdiagnosed as a giant cell tumor of the bone

Sarah Hamidi, Sophie Mottard, Marie-Josée Berthiaume et al. · Endocrinology Diabetes and Metabolism Case Reports · 2020 · 19 citations · Full text

RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions

Sarah Hamidi, Mimi I. Hu · Annales d Endocrinologie · 2024 · 12 citations

1–5 of 5